The volumes over the last few days have been huge. In fact, they have been increasing, and the average for last ten days is 1.36 million. This is double the three month average. The stock has declined by 23% during the last 5 days. Compared to the high of $4.92 in July, the stock has crashed by 50%. The shorts have increased over the last couple of weeks. The percentage level on September 30 was around 24%. The news related to start of the trial in the patent infringement lawsuit against Qualcomm (QCOM) has increased the selling. The trial will be conducted in two parts. First the jury will determine whether there is an infringement. If the jury holds that Qualcomm has infringed upon Parkervision's rights, then it will determine the damages in the next stage. All this points to the negative perceptions about the future of the trial. This is also evident from the opinions expressed by several analysts. Not many expect the first stage to be crossed so the weakness may only increase. If there is some adverse news, then it is easy to imagine the fate of the already weak stock. The company has sought $500 million in damages, which is more than double the current market cap of the company. The stock had moved remarkably in anticipation of the success of the trial. Hopes were high after the Markman hearing went in favor of the company. There was always a risk associated with being dependent on the success of a single event. Several companies have realized the importance of having a diversified portfolio. Spherix (SPEX), a full service IP company has recently built up a diversified portfolio comprising of hundreds of patents. Parkervision has now come to crucial levels, and it is imperative that it bounces fast, else it may sink to much lower levels.